Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thyroid Diseases 1Parathyroid Diseases 1Neurilemmoma 1Neoplasms 1Meningioma 1Lung Neoplasms 1Low Grade Glioma of Brain 1Liver Neoplasms 1Inflammatory Bowel Diseases 1Inflammation 1Glioma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

tanezumab 1siltuximab 1erenumab 1antineoplaston AS 2-1 1antineoplaston A10 1Saline Solution 1Radiosurgery 1Radiation Dose Hypofractionation 1Protons 1Proton Therapy 1Lapatinib 1Hyperspectral Imaging 1HDAC-42 1Bevacizumab 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurilemmoma × Hyperspectral Imaging × Clear all
NCT04712214 2023-04-25

Use of Non-invasive Optical Analysis in Neurosurgery

Imperial College London

Phase NA Unknown
50 enrolled
CNS

Brain Neoplasms, Glioma, Meningioma, Neurilemmoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡